Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
ICICI Pru Nifty Pharma Index Fund IDCW Direct |
[Equity: Sectoral] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
-0.56 |
Equity |
99.34 |
Trep |
1.22 |
|
|
Concentration Analysis |
Top 5 Holdings |
60.88% |
Top 10 Holdings |
79.86% |
Top 25 Holdings |
100.00% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
99.34 |
Cash |
0.66 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
5.26 |
PE Ratio |
33.74 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
24.74 |
Cipla Limited |
10.73 |
DIVI LABORATORIES LTD |
9.70 |
Dr Reddys Laboratories Limited |
9.23 |
Lupin Limited |
6.48 |
Torrent Pharmaceuticals Limited |
4.46 |
Aurobindo Pharma Limited |
4.29 |
MANKIND PHARMA LIMITED |
3.62 |
Alkem Laboratories Limited |
3.43 |
Laurus Labs Limited |
3.18 |
Glenmark Pharmaceuticals Limited |
3.07 |
Zydus Lifesciences Limited |
2.93 |
IPCA Laboratories Limited |
2.76 |
Abbott India Limited |
2.12 |
Biocon Limited |
2.04 |
Gland Pharma Limited |
1.68 |
J B Chemicals and Pharma Ltd |
1.54 |
Ajanta Pharma Limited |
1.46 |
TREPS |
1.22 |
Natco Pharma Limited |
0.95 |
Granules India Limited |
0.93 |
Net Current Assets |
-0.56 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
 |
|
|
|
|